serogroup


Also found in: Medical, Wikipedia.

serogroup

(ˈsɪərəʊˌɡruːp)
n
a group of bacteria with a common antigen
References in periodicals archive ?
pneumophila serogroup 1 in the water from 2 of the 4 trucks sampled.
IN OCTOBER 2014 AND JANUARY 2015, the Food and Drug Administration licensed two meningococcal serogroup B vaccines for administration in adolescents and young adults aged 10-25 years based on each vaccine's ability to elicit bactericidal antibody against the majority of invasive serogroup B strains and demonstrated safety.
Two serogroup B meningococcal (MenB) vaccines are currently licensed for use in persons aged 10-25 years in the United States.
Children are immunised against meningococcal serogroup C at 14 months.
s (NYSE: PFE) Trumenba (Meningococcal Group B Vaccine) be granted marketing authorisation in the European Union for active immunisation of individuals ten years and older to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B, the company said.
The European Medicines Agency's CHMP has adopted a positive opinion recommending the company's TRUMENBA's (Meningococcal Group B Vaccine) marketing authorisation in the EU for active immunisation of individuals ten years and older to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB).
37% of the laboratory-confirmed incident cases of IMD are serogroup C disease, 36.
A recommendation to expand serogroup B meningococcal vaccination to include adolescents and young adults was supported by the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.
A recommendation to expand serogroup B meningococcal vaccination to include adolescents and young adults, including college students, was supported by the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices, at a meeting on June 24.
Leptospira interrogans serogroup Autumnalis, canicola, grippotyphosa, icterohaemorrhagiae, pomona and pyrogens are used in this study.
26, ACIP voted 15-0 for vaccination for the following people over age 10 years at increased risk of serogroup B meningococcal disease: those with persistent complement deficiencies; those with anatomic or functional asplenia; microbiologists exposed to Neisseria meningitidis isolates; and those such as college students at increased risk during an outbreak.